Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s13300-020-00848-4
Published Online: 2020-06-13
Published Print: 2020-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Linnebjerg, Helle
LaBell, Elizabeth Smith
Dellva, Mary Anne
Coutant, David E.
Leohr, Jennifer
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 30 April 2020
First Online: 13 June 2020